SBC Medical Group Holdings Incorporated (SBC) 株式分析

企業概要

SBC Medical Group Holdings Incorporated operates by providing comprehensive management services to a network of cosmetic treatment centers across Japan, Vietnam, the United States, and Singapore, alongside offering advertising, marketing, and staff management solutions through social media platforms. The firm is categorized within the Industrials sector and specifically functions in the Consulting Services industry, a classification that highlights its role as a specialized service provider rather than a manufacturer or retailer of physical goods. As of the latest reporting period, the company maintains a market capitalization of $445.18M, generates annual revenue of $173.61M, and employs a workforce of 863 individuals to execute its operational strategy. These valuation and revenue figures position SBC as a mid-cap entity with a significant operational footprint in the aesthetic medicine management space, indicating a stable scale that allows for diversified geographic exposure while maintaining a focused service-oriented business model.

財務健全性

The company reported a trailing twelve-month revenue of $173.61M, which generated a net income of $50.99M and an EBITDA of $70.17M, illustrating a robust cost structure where operating expenses are managed efficiently relative to total sales volume. The free cash flow stands at $25.41M, demonstrating strong cash generation capabilities that provide the management with significant financial flexibility to fund operations, service clients, or potentially return capital without relying heavily on external financing. Profitability analysis reveals a gross margin of 73.3%, an operating margin of 32.5%, and a profit margin of 29.4%, all of which indicate highly efficient operations where the majority of revenue translates directly into earnings after accounting for the cost of services and overhead. The balance sheet shows a cash position of $164.09M against total debt of $51.64M, resulting in a debt-to-equity ratio of 19.61, which suggests a conservative capital structure with ample liquidity to cover obligations. Short-term liquidity is exceptionally strong, evidenced by a current ratio of 3.78, meaning the company holds more than three times the current assets necessary to meet its short-term liabilities. Return on equity is calculated at 22.3% while return on assets sits at 13.0%, metrics that collectively reveal highly effective management in generating returns on shareholders' capital and utilizing the asset base productively.

バリュエーション評価

Valuation multiples indicate a trailing P/E ratio of 8.68 and a forward P/E of 8.68, implying that the market expects earnings to remain stable with no immediate projected growth trajectory that would alter the earnings multiple in the near term. The price-to-book ratio is recorded at 1.79, suggesting that the market values the company at a modest premium over its tangible book value, reflecting the intangible nature of its consulting and management services. Alternative valuation metrics such as a price-to-sales ratio of 2.56 and an EV/EBITDA of 4.96 further characterize the asset as being priced conservatively relative to its sales volume and earnings before interest, taxes, depreciation, and amortization. The stock has traded within a 52-week range bounded by a high of $5.75 and a low of $2.97, and based on the provided data points, the current valuation metrics sit within this historical band, reflecting a stock that has experienced significant volatility over the past year. The beta coefficient is 0.99, which indicates that the stock's price volatility moves in tandem with the broader market, lacking significant idiosyncratic risk or defensive characteristics that would cause it to diverge from general market trends.

Growth & Income

Revenue growth for the trailing twelve months stands at -10.9%, while earnings growth is reported at 117.5%, indicating that earnings are expanding at a rate significantly faster than revenue due to substantial year-over-year improvements in profitability rather than top-line expansion. The company does not distribute dividends to shareholders, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means the firm retains all of its net income of $50.99M to reinvest into business operations, debt reduction, or strategic acquisitions rather than paying out cash. This reinvestment strategy aligns with the growth profile where earnings growth outpaces revenue decline, suggesting management is prioritizing capital efficiency and margin expansion over immediate income distribution. The overall growth and income profile presents a scenario of capital preservation through high cash balances and aggressive earnings per share improvement, compensating for the lack of current yield and recent revenue contraction.